The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Michael Böhm
Showing 1-14 of 14 articles
Prioritised endpoints for device-based hypertension trials: the win ratio methodology
Kandzari D,
Hickey G,
Pocock S,
Weber M,
Böhm M,
Cohen S,
Fahy M,
Lamberti G,
Mahfoud F
April 2, 2021 | 10.4244/EIJ-D-20-01090
Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation
Townsend R,
Walton A,
Hettrick D,
Hickey G,
Weil J,
Sharp A,
Blankestijn P,
Böhm M,
Mancia G
May 20, 2020 | 10.4244/EIJ-D-19-00902
Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial
Scheller B,
Ohlow M,
Ewen S,
Kische S,
Rudolph T,
Clever Y,
Wagner A,
Richter S,
El-Garhy M,
Böhm M,
Degenhardt R,
Mahfoud F,
Lauer B
April 17, 2020 | 10.4244/EIJ-D-19-00723
Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension
Lauder L,
Ewen S,
Tzafriri A,
Edelman E,
Lüscher T,
Blankestijn P,
Dörr O,
Schlaich M,
Sharif F,
Voskuil M,
Zeller T,
Ukena C,
Scheller B,
Böhm M,
Mahfoud F
May 20, 2018 | 10.4244/EIJ-D-18-00112
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)
Lauten A,
Figulla HR,
Möllmann H,
Holzhey D,
Kotting J,
Beckmann A,
Veit C,
Cremer J,
Kuck K,
Lange R,
Zahn R,
Sack S,
Schuler G,
Walther T,
Beyersdorf F,
Böhm M,
Heusch G,
Meinertz T,
Neumann T,
Welz A,
Mohr F,
Hamm C
November 20, 2014 | 10.4244/EIJV10I7A145
Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation
Lenski D,
Kindermann I,
Lenski M,
Ukena C,
Bunz M,
Mahfoud F,
Böhm M
October 25, 2013 | 10.4244/EIJV9I6A114
Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry
Böhm M,
Mahfoud F,
Ukena C,
Bauer A,
Fleck E,
Hoppe U,
Kintscher U,
Narkiewicz K,
Negoita M,
Ruilope L,
Rump L,
Schlaich M,
Schmieder R,
Sievert H,
Weil J,
Williams B,
Zeymer U,
Mancia G
August 23, 2013 | 10.4244/EIJV9I4A78
Response and non-response to renal denervation: who is the ideal candidate?
Ukena C,
Cremers B,
Ewen S,
Böhm M,
Mahfoud F
May 21, 2013 | 10.4244/EIJV9SRA10
Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias
Ukena C,
Mahfoud F,
Linz D,
Böhm M,
Neuberger H-R
May 21, 2013 | 10.4244/EIJV9SRA19
Expanding the indication spectrum: renal denervation in diabetes
Mahfoud F,
Ewen S,
Ukena C,
Linz D,
Sobotka P,
Cremers B,
Böhm M
May 21, 2013 | 10.4244/EIJV9SRA20
Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure
Böhm M,
Ewen S,
Linz D,
Reil J-C,
Schirmer S,
Ukena C,
Mahfoud F
May 21, 2013 | 10.4244/EIJV9SRA21
First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B
Ewen S,
Mahfoud F,
Böhm M
January 18, 2013 | 10.4244/EIJV8I9A170
Paclitaxel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study
Fischer D,
Scheller B,
Schäfer A,
Klein G,
Böhm M,
Clever Y,
Cremers B
August 24, 2012 | 10.4244/EIJV8I4A71
Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells
Clever Y,
Cremers B,
Krauß B,
Böhm M,
Speck U,
Laufs U,
Scheller B
May 17, 2011
1
Latest news
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
AHEAD OF PRINT
Antithrombotic strategy selection using smartphone technology
FREE ARTICLE - Jaya Chandrasekhar et al
June 3, 2022
AHEAD OF PRINT
The fingerprints of plaque rupture healing as detected by serial OCT imaging
FREE ARTICLE - Rocco Vergallo et al
June 2, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke